Aspiculamycin, a new cytosine nucleoside antibiotic. 3. Biological activities, in vitro and in vivo.
D000818:Animals; D000871:Anthelmintics / Q000494:pharmacology; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001200:Ascaris / Q000187:drug effects; D001419:Bacteria / Q000187:drug effects*; D003597:Cytosine Nucleotides / Q000494:pharmacology*; D004757:Enterobius / Q000187:drug effects; D005243:Feces / Q000382:microbiology; D051379:Mice; D009174:Mycoplasma / Q000187:drug effects; D010270:Parasite Egg Count
D000871:Anthelmintics; D000900:Anti-Bacterial Agents; D003597:Cytosine Nucleotides